Aprea Therapeutics, Inc. (APRE)
Stock-Based Compensation
$427.04K
TTM · Period ending: · USD
APRE Stock-Based Compensation
Latest reported$427.04Kperiod ending
Latest reported$427.04Kperiod ending
APRE Stock-Based Comp ($395.44K → $427.04K)
Annual stock-based compensation
High-resolution chart · PNG
APRE stock-based compensation history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 478,141 | |
| 489,436 | |
| 444,459 | |
| 16,981,266 | |
| 7,813,743 | |
| 4,983,023 | |
| 1,345,722 | |
| 329,184 | |
| 395,440 |